Free Trial
OTCMKTS:NVZMY

Novozymes A/S (NVZMY) Stock Price, News & Analysis

Novozymes A/S logo
$60.32 -1.35 (-2.19%)
As of 09/22/2025 03:59 PM Eastern

About Novozymes A/S Stock (OTCMKTS:NVZMY)

Advanced

Key Stats

Today's Range
$60.10
$61.00
50-Day Range
$60.32
$70.25
52-Week Range
$53.95
$75.99
Volume
29,769 shs
Average Volume
42,197 shs
Market Capitalization
$28.25 billion
P/E Ratio
38.18
Dividend Yield
0.61%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVZMY Stock News Headlines

Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
Novozymes A/S (NSIS-B.CO) - Yahoo Finance
NVZMY Novozymes A/S - Seeking Alpha
See More Headlines

NVZMY Stock Analysis - Frequently Asked Questions

Novozymes A/S's stock was trading at $56.5399 at the beginning of 2025. Since then, NVZMY shares have increased by 6.7% and is now trading at $60.32.

Novozymes A/S (OTCMKTS:NVZMY) released its quarterly earnings results on Wednesday, January, 31st. The biotechnology company reported $0.36 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by $0.11. The biotechnology company had revenue of $664.46 million for the quarter.

The following companies are subsidiaries of Novozymes A/S: PrecisionBiotics Group Limited, OrganoBalance GmbH, Pacific Vet Group-USA, Allopartis, TJ Technologies, Iogen Bio-Products, Natural Industries, and others.

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
1/31/2024
Ex-Dividend for 9/11 Dividend
9/02/2025
Record date for 9/11 Dividend
9/03/2025
Dividend Payable
9/11/2025
Today
9/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
CHEM - SPECIALTY
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMY
Previous Symbol
OTC:NVZMY
CIK
1131345
Employees
10,582
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
38.18
Forward P/E Ratio
33.14
P/E Growth
1.21
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
1.75
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$4.15 billion
Price / Sales
6.81
Cash Flow
$1.82 per share
Price / Cash Flow
33.21
Book Value
$25.82 per share
Price / Book
2.34

Miscellaneous

Outstanding Shares
468,300,000
Free Float
N/A
Market Cap
$28.25 billion
Optionable
Not Optionable
Beta
0.93

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:NVZMY) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners